Literature DB >> 3367095

A 52-kD protein is a novel component of the SS-A/Ro antigenic particle.

E Ben-Chetrit1, E K Chan, K F Sullivan, E M Tan.   

Abstract

Anti-SS-A/Ro autoantibodies are found in the sera of patients with Sjogren's syndrome (SS) and SLE. In the course of analyzing 61 SS patients for their autoantibody profiles, we found that 42 were positive for anti-SS-A by double diffusion in agarose and demonstrated precipitin lines identical to that produced by a prototype anti-SS-A serum. Further analysis of these SS-A antibody-positive sera by Western blotting of cell extracts revealed that 21 sera reacted with two proteins of 60 and 52 kD, 13 sera reacted with 52-kD protein, two detected only 60 kD, while six were nonreactive. Affinity-purified anti-60-kD and anti-52-kD antibodies reacted exclusively with their corresponding antigens. Partial proteolysis of these proteins did not reveal common degradation fragments. Thus the 52- and 60-kD proteins were found to be antigenically and apparently structurally distinct from each other. They were also distinct from 48-kD SS-B/La protein. In immunoprecipitation using labeled cell extracts, affinity-purified anti-52-kD antibodies brought down the 52-kD protein as well as the 60-kD band. In [32P]orthophosphate-labeled HeLa cell extract both antibodies precipitated the same spectrum of small RNAs (hYl-5). In indirect immunofluorescence, anti-52-kD and anti-60-kD antibodies immunolocalized in similar subcellular structures and showed similar punctate nuclear staining patterns. Western blot analysis revealed that both proteins were present in lymphocytic as well as epithelial human cell lines tested. The data above define a new antigen of 52 kD which is another component of the SS-A particle and is associated in complex formation with the previously reported 60-kD protein.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3367095      PMCID: PMC2188933          DOI: 10.1084/jem.167.5.1560

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

1.  Fine specificities of autoantibodies directed against the Ro, La, Sm, RNP, and Jo-1 proteins defined by two-dimensional gel electrophoresis and immunoblotting.

Authors:  K B Elkon; P W Jankowski
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

2.  Autoimmune sera reactive with Sm antigen contain high levels of RNP-like antibodies.

Authors:  W H Reeves; D E Fisher; R G Lahita; H G Kunkel
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

3.  Identification of human Sm and (U1) RNP antigens by immunoblotting.

Authors:  H H Guldner; H J Lakomek; F A Bautz
Journal:  J Immunol Methods       Date:  1983-11-11       Impact factor: 2.303

4.  Molecular properties of the Ro/SSA antigen and enzyme-linked immunosorbent assay for quantitation of antibody.

Authors:  H Yamagata; J B Harley; M Reichlin
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

5.  Identification of the SS-A/Ro intracellular antigen with autoimmune sera.

Authors:  T S Lieu; M Jiang; J C Steigerwald; E M Tan
Journal:  J Immunol Methods       Date:  1984-07-06       Impact factor: 2.303

6.  The importance of tissue substrate in the SS-A/Ro antigen-antibody system.

Authors:  C E Harmon; J S Deng; C L Peebles; E M Tan
Journal:  Arthritis Rheum       Date:  1984-02

7.  Partial immunochemical characterization of the Ro and La proteins using antibodies from patients with the sicca syndrome and lupus erythematosus.

Authors:  K B Elkon; L Culhane
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

8.  Genes for two small cytoplasmic Ro RNAs are adjacent and appear to be single-copy in the human genome.

Authors:  S L Wolin; J A Steitz
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

9.  Molecular characteristics of SS-B/La and SS-A/Ro cellular antigens.

Authors:  J S Deng; R D Sontheimer; J N Gilliam
Journal:  J Invest Dermatol       Date:  1985-02       Impact factor: 8.551

10.  The Ro small cytoplasmic ribonucleoproteins: identification of the antigenic protein and its binding site on the Ro RNAs.

Authors:  S L Wolin; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

View more
  117 in total

1.  Ro/SSA and La/SSB specific IgA autoantibodies in serum of patients with Sjögren's syndrome and systemic lupus erythematosus.

Authors:  N Pourmand; M Wahren-Herlenius; I Gunnarsson; E Svenungsson; B Löfström; Y Ioannou; D A Isenberg; C G Magnusson
Journal:  Ann Rheum Dis       Date:  1999-10       Impact factor: 19.103

2.  Antibodies to extractable nuclear antigens. Has technological drift affected clinical interpretation?

Authors:  R J Lock; D J Unsworth
Journal:  J Clin Pathol       Date:  2001-03       Impact factor: 3.411

3.  Identification of a novel cis-acting RNA element involved in nuclear export of hY RNAs.

Authors:  S A Rutjes; E Lund; A van der Heijden; C Grimm; W J van Venrooij; G J Pruijn
Journal:  RNA       Date:  2001-05       Impact factor: 4.942

4.  Specificity of autoantibodies to SS-A/Ro on a transfected and overexpressed human 60 kDa Ro autoantigen substrate.

Authors:  Marvin J Fritzler; Cheryl Hanson; Joan Miller; Theophany Eystathioy
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

5.  IgG antibodies from patients with primary Sjögren's syndrome and systemic lupus erythematosus recognize different epitopes in 60-kD SSA/Ro protein.

Authors:  S Barakat; O Meyer; F Torterotot; P Youinou; J P Briand; M F Kahn; S Muller
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

Review 6.  B-cell epitopes of La and Ro autoantigens.

Authors:  S Whittingham
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

7.  The Ro60 autoantigen binds endogenous retroelements and regulates inflammatory gene expression.

Authors:  T Hung; G A Pratt; B Sundararaman; M J Townsend; C Chaivorapol; T Bhangale; R R Graham; W Ortmann; L A Criswell; G W Yeo; T W Behrens
Journal:  Science       Date:  2015-09-17       Impact factor: 47.728

Review 8.  Sjögren's syndrome--study of autoantigens and autoantibodies.

Authors:  John G Routsias; Athanasios G Tzioufas
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

9.  Xenopus Ro ribonucleoproteins: members of an evolutionarily conserved class of cytoplasmic ribonucleoproteins.

Authors:  C A O'Brien; K Margelot; S L Wolin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

10.  Calreticulin synthetic peptide analogues: anti-peptide antibodies in autoimmune rheumatic diseases.

Authors:  J G Routsias; A G Tzioufas; M Sakarellos-Daitsiotis; C Sakarellos; H M Moutsopoulos
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.